Literature DB >> 23799373

Liver cancer: SALL4--a cancer marker and target.

Bryony Jones.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23799373     DOI: 10.1038/nrclinonc.2013.112

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.

Authors:  Kol Jia Yong; Chong Gao; Joline S J Lim; Benedict Yan; Henry Yang; Todor Dimitrov; Akira Kawasaki; Chee Wee Ong; Kwong-Fai Wong; Sanghoon Lee; Sharada Ravikumar; Supriya Srivastava; Xi Tian; Ronnie T Poon; Sheung Tat Fan; John M Luk; Yock Young Dan; Manuel Salto-Tellez; Li Chai; Daniel G Tenen
Journal:  N Engl J Med       Date:  2013-06-13       Impact factor: 91.245

  1 in total
  4 in total

1.  The Invasion and Metastasis of Colon Adenocarcinoma (COAD) Induced by SALL4.

Authors:  Wenjuan Zhang; Yan Hu; Wenbing Zhang; Ke Yi; Xiaohui Xu; Zhihua Chen
Journal:  J Immunol Res       Date:  2022-06-01       Impact factor: 4.493

2.  Serum SALL4 is a novel prognosis biomarker with tumor recurrence and poor survival of patients in hepatocellular carcinoma.

Authors:  Su-xia Han; Jun-lan Wang; Xi-jing Guo; Chen-chen He; Xia Ying; Jin-lu Ma; Yuan-yuan Zhang; Qian Zhao; Qing Zhu
Journal:  J Immunol Res       Date:  2014-04-17       Impact factor: 4.818

Review 3.  The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy.

Authors:  Yanhong Xiao; Mei Lin; Xingmao Jiang; Jun Ye; Ting Guo; Yujuan Shi; Xuefeng Bian
Journal:  Anal Cell Pathol (Amst)       Date:  2017-07-27       Impact factor: 2.916

4.  Oncofetal gene SALL4 reactivation by hepatitis B virus counteracts miR-200c in PD-L1-induced T cell exhaustion.

Authors:  Cheng Sun; Peixiang Lan; Qiuju Han; Mei Huang; Zhihong Zhang; Geliang Xu; Jiaxi Song; Jinyu Wang; Haiming Wei; Jian Zhang; Rui Sun; Cai Zhang; Zhigang Tian
Journal:  Nat Commun       Date:  2018-03-28       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.